Literature DB >> 33194037

Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis.

Xuanlin Shen1, Yuting Ding1, Feng Lu2, Haitao Yuan3, Wenkang Luan2.   

Abstract

Long noncoding RNAs (lncRNAs) play the critical biological role in many malignant tumours. MIR4435-2HG has been proven to be a novel oncogenic lncRNA. However, the exact role and mechanism of MIR4435-2HG in hepatocellular carcinoma (HCC) remain unclear. Here, we found that MIR4435-2HG is overexpressed in HCC tissue compared to normal controls and that high level of MIR4435-2HG indicates a poorer prognosis in HCC patients. MIR4435-2HG enhances the growth and metastasis ability of HCC cells. MIR4435-2HG promotes the expression of YWHAZ by sponging miR-22-3p to liberate YWHAZ mRNA transcripts. MIR4435-2HG facilitates the proliferation and metastasis of HCC by modulating the miR-22-3p/YWHAZ axis. These results demonstrated the role and mechanism of MIR4435-2HG in malignant progression of HCC. MIR4435-2HG may be used as the prognostic marker and treatment target for the patient with HCC. AJTR
Copyright © 2020.

Entities:  

Keywords:  HCC; MIR4435-2HG; YWHAZ; miR-22-3p; proliferation and metastasis

Year:  2020        PMID: 33194037      PMCID: PMC7653602     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  36 in total

Review 1.  The evolving epidemiology of hepatocellular carcinoma: a global perspective.

Authors:  Michael C Wallace; David Preen; Gary P Jeffrey; Leon A Adams
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-04-01       Impact factor: 3.869

2.  MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.

Authors:  G-Y Wei; M Hu; L Zhao; W-S Guo
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-06       Impact factor: 3.507

3.  LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway.

Authors:  Wei Zong; Wei Feng; Yun Jiang; Yaning Cao; Yuchen Ke; Xin Shi; Shaoqing Ju; Hui Cong; Xudong Wang; Ming Cui; Rongrong Jing
Journal:  Gastric Cancer       Date:  2019-08-26       Impact factor: 7.370

4.  PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.

Authors:  Wenkang Luan; Yingyi Wang; Xincheng Chen; Yan Shi; Jiajia Wang; Junxia Zhang; Jin Qian; Ri Li; Tao Tao; Wenjin Wei; Qi Hu; Ning Liu; Yongping You
Journal:  Oncotarget       Date:  2015-05-30

5.  The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.

Authors:  Juan-Feng Zhao; Qiu Zhao; Hui Hu; Jia-Zhi Liao; Ju-Sheng Lin; Chao Xia; Ying Chang; Jing Liu; An-Yuan Guo; Xing-Xing He
Journal:  Mol Ther Nucleic Acids       Date:  2018-04-25       Impact factor: 8.886

6.  lncRNA MIR4435-2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF-β1.

Authors:  Hui Zhang; Hao Meng; Xiaona Huang; Wenting Tong; Xiaoxin Liang; Junlong Li; Changrong Zhang; Ming Chen
Journal:  Oncol Lett       Date:  2019-08-16       Impact factor: 2.967

Review 7.  Long non-coding RNA: a new player in cancer.

Authors:  Hua Zhang; Zhenhua Chen; Xinxin Wang; Zunnan Huang; Zhiwei He; Yueqin Chen
Journal:  J Hematol Oncol       Date:  2013-05-31       Impact factor: 17.388

8.  lncRNA miat functions as a ceRNA to upregulate sirt1 by sponging miR-22-3p in HCC cellular senescence.

Authors:  Lijun Zhao; Kexin Hu; Jianzhong Cao; Pan Wang; Jun Li; Kewu Zeng; Xiaodong He; Peng-Fei Tu; Tanjun Tong; Limin Han
Journal:  Aging (Albany NY)       Date:  2019-09-10       Impact factor: 5.682

9.  Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis.

Authors:  Wenkang Luan; Yuting Ding; Shaojun Ma; Hongru Ruan; Jinlong Wang; Feng Lu
Journal:  Cell Death Dis       Date:  2019-11-11       Impact factor: 8.469

10.  Long non-coding RNA ZEB1-AS1 promotes colon adenocarcinoma malignant progression via miR-455-3p/PAK2 axis.

Authors:  Xin Ni; Yuting Ding; Haitao Yuan; Jinmin Shao; Yan Yan; Rouyu Guo; Wenkang Luan; Min Xu
Journal:  Cell Prolif       Date:  2019-12-12       Impact factor: 6.831

View more
  13 in total

1.  LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.

Authors:  Jing Ke; Quhui Wang; Wei Zhang; Sujie Ni; Haijun Mei
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

Review 2.  MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis.

Authors:  Chenming Zhong; Zijun Xie; Ling-Hui Zeng; Chunhui Yuan; Shiwei Duan
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

3.  Construction of a Prognostic Model for Hypoxia-Related LncRNAs and Prediction of the Immune Landscape in the Digestive System Pan-Cancer.

Authors:  Zikang He; Hongfeng Liu; Huilin Guan; Jinli Ji; Ying Jiang; Naiwen Zhang; Zheyao Song; Xingyun Wang; Ping Shen; Huan Wang; Rongjun Cui
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

4.  Construction and Comprehensive Analysis of a circRNA-miRNA-mRNA Regulatory Network to Reveal the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Meile Mo; Bihu Liu; Yihuan Luo; Jennifer Hui Juan Tan; Xi Zeng; Xiaoyun Zeng; Dongping Huang; Changhua Li; Shun Liu; Xiaoqiang Qiu
Journal:  Front Mol Biosci       Date:  2022-01-24

5.  ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.

Authors:  Guozheng Pan; Jian Zhang; Faping You; Tao Cui; Peng Luo; Shuling Wang; Xiaomei Li; Qingzhong Yuan
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.

Authors:  Li Zhang; Shangshang Hu; Jiasheng Chen; Shasha Ma; Fanghong Liu; Chuanmiao Liu; Yu Gao
Journal:  Discov Oncol       Date:  2021-10-07

7.  lncRNA MIR4435‑2HG promotes the progression of liver cancer by upregulating B3GNT5 expression.

Authors:  Yungang Zhu; Baoguo Li; Guoping Xu; Changrui Han; Gang Xing
Journal:  Mol Med Rep       Date:  2021-12-03       Impact factor: 2.952

8.  High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma.

Authors:  Guochao Mao; Changyou Shan; Weimiao Li; Baobao Liang; Li Ma; Shuqun Zhang
Journal:  Int J Gen Med       Date:  2022-03-06

Review 9.  Regulatory Roles of Noncoding RNAs in the Progression of Gastrointestinal Cancers and Health Disparities.

Authors:  Aditi Kulkarni; Sharan Gayathrinathan; Soumya Nair; Anamika Basu; Taslim A Al-Hilal; Sourav Roy
Journal:  Cells       Date:  2022-08-07       Impact factor: 7.666

10.  Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling.

Authors:  Wei Zheng; Guo-Liang Shen; Ke-Yang Xu; Qiao-Qiao Yin; Tian-Chen Hui; Zhe-Wen Zhou; Cheng-An Xu; Shou-Hao Wang; Wen-Hao Wu; Ling-Fei Shi; Hong-Ying Pan
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.